297 related articles for article (PubMed ID: 21384087)
1. Efficacy of infliximab for hidradenitis suppurativa: assessment of clinical and biological inflammatory markers.
Delage M; Samimi M; Atlan M; Machet L; Lorette G; Maruani A
Acta Derm Venereol; 2011 Mar; 91(2):169-71. PubMed ID: 21384087
[TBL] [Abstract][Full Text] [Related]
2. Infliximab for severe hidradenitis suppurativa: transient clinical efficacy in 7 consecutive patients.
Fardet L; Dupuy A; Kerob D; Levy A; Allez M; Begon E; Bachelez H; Morel P; Lebbé C
J Am Acad Dermatol; 2007 Apr; 56(4):624-8. PubMed ID: 17240478
[TBL] [Abstract][Full Text] [Related]
3. Long-term efficacy of a single course of infliximab in hidradenitis suppurativa.
Mekkes JR; Bos JD
Br J Dermatol; 2008 Feb; 158(2):370-4. PubMed ID: 18047504
[TBL] [Abstract][Full Text] [Related]
4. Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial.
Grant A; Gonzalez T; Montgomery MO; Cardenas V; Kerdel FA
J Am Acad Dermatol; 2010 Feb; 62(2):205-17. PubMed ID: 20115947
[TBL] [Abstract][Full Text] [Related]
5. New-onset polyarthritis during successful treatment of hidradenitis suppurativa with infliximab.
van Rappard DC; Mooij JE; Baeten DL; Mekkes JR
Br J Dermatol; 2011 Jul; 165(1):194-8. PubMed ID: 21428974
[TBL] [Abstract][Full Text] [Related]
6. Infliximab for the treatment of hidradenitis suppurativa.
Fernández-Vozmediano JM; Armario-Hita JC
Dermatology; 2007; 215(1):41-4. PubMed ID: 17587838
[TBL] [Abstract][Full Text] [Related]
7. Comparing treatment outcome of infliximab and adalimumab in patients with severe hidradenitis suppurativa.
van Rappard DC; Leenarts MF; Meijerink-van 't Oost L; Mekkes JR
J Dermatolog Treat; 2012 Aug; 23(4):284-9. PubMed ID: 21756155
[TBL] [Abstract][Full Text] [Related]
8. Effective long-term control of refractory hidradenitis suppurativa with adalimumab after failure of conventional therapy.
Arenbergerova M; Gkalpakiotis S; Arenberger P
Int J Dermatol; 2010 Dec; 49(12):1445-9. PubMed ID: 21091684
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerance of prolonged infliximab treatment of moderate-to-severe forms of hidradenitis suppurativa.
Lesage C; Adnot-Desanlis L; Perceau G; Bonnet M; Palot JP; Bernard P; Reguiaï Z
Eur J Dermatol; 2012; 22(5):640-4. PubMed ID: 22759562
[TBL] [Abstract][Full Text] [Related]
10. Long-term efficacy of infliximab in hidradenitis suppurativa.
Paradela S; Rodríguez-Lojo R; Fernández-Torres R; Arévalo P; Fonseca E
J Dermatolog Treat; 2012 Aug; 23(4):278-83. PubMed ID: 22482700
[TBL] [Abstract][Full Text] [Related]
11. [Hidradenitis suppurativa. Response to treatment with infliximab].
Pedraz J; Daudén E; Pérez-Gala S; Goiriz-Valdés R; Fernández-Peñas P; García-Diez A
Actas Dermosifiliogr; 2007 Jun; 98(5):325-31. PubMed ID: 17555675
[TBL] [Abstract][Full Text] [Related]
12. Long-term successful adalimumab therapy in severe hidradenitis suppurativa.
Blanco R; Martínez-Taboada VM; Villa I; González-Vela MC; Fernández-Llaca H; Agudo M; González-López MA
Arch Dermatol; 2009 May; 145(5):580-4. PubMed ID: 19451504
[TBL] [Abstract][Full Text] [Related]
13. A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa.
Miller I; Lynggaard CD; Lophaven S; Zachariae C; Dufour DN; Jemec GB
Br J Dermatol; 2011 Aug; 165(2):391-8. PubMed ID: 21457202
[TBL] [Abstract][Full Text] [Related]
14. Is there a role for infliximab in the current therapy of hidradenitis suppurativa? A report of three treated cases.
Moschella SL
Int J Dermatol; 2007 Dec; 46(12):1287-91. PubMed ID: 18173525
[TBL] [Abstract][Full Text] [Related]
15. SAPHO syndrome associated with hidradenitis suppurativa successfully treated with infliximab and methotrexate.
De Souza A; Solomon GE; Strober BE
Bull NYU Hosp Jt Dis; 2011; 69(2):185-7. PubMed ID: 22035400
[TBL] [Abstract][Full Text] [Related]
16. Hidradenitis suppurativa responding to treatment with infliximab.
Lasocki A; Sinclair R; Foley P; Saunders H
Australas J Dermatol; 2010 Aug; 51(3):186-90. PubMed ID: 20695857
[TBL] [Abstract][Full Text] [Related]
17. Etanercept: effective in the management of hidradenitis suppurativa.
Cusack C; Buckley C
Br J Dermatol; 2006 Apr; 154(4):726-9. PubMed ID: 16536817
[TBL] [Abstract][Full Text] [Related]
18. Treatment of severe hidradenitis suppurativa with infliximab in combination with surgical interventions.
Van Rappard DC; Mekkes JR
Br J Dermatol; 2012 Jul; 167(1):206-8. PubMed ID: 22229974
[No Abstract] [Full Text] [Related]
19. An open-label phase II study of the safety and efficacy of etanercept for the therapy of hidradenitis suppurativa.
Giamarellos-Bourboulis EJ; Pelekanou E; Antonopoulou A; Petropoulou H; Baziaka F; Karagianni V; Stavrianeas N; Giamarellou H
Br J Dermatol; 2008 Mar; 158(3):567-72. PubMed ID: 18076705
[TBL] [Abstract][Full Text] [Related]
20. Amyloidosis secondary to hidradenitis suppurativa. Exceptional response to infliximab.
Montes-Romero JA; Callejas-Rubio JL; Sánchez-Cano D; González-Martínez FJ; Navas-Parejo A; Ortego-Centeno N
Eur J Intern Med; 2008 Oct; 19(6):e32-3. PubMed ID: 18848164
[No Abstract] [Full Text] [Related]
[Next] [New Search]
